申请人:The Upjohn Company
公开号:US05436240A1
公开(公告)日:1995-07-25
Tricyclic nitrogen containing compounds, having central nervous system activity of the following structural formula: ##STR1## and pharmaceutically acceptable salts thereof wherein R.sub.1, R.sub.2, and R.sub.3 are independently hydrogen, C.sub.1-6 alkyl, alkenyl, or alkynyl, C.sub.3-10 cycloalkyl, or R.sub.1 and R.sub.2 are joined to form a C.sub.3-7 cyclic amine which can contain additional heteroatoms; X is hydrogen, C.sub.1-6 alkyl, halogen, hydroxy, alkoxy, cyano, carboxamide, carboxyl, or carboalkoxyl; A is SO.sub.2, N, CH, CH.sub.2, CHCH.sub.3, C=O, C=S, C-SCH.sub.3, C=NH, C-NH.sub.2, C-NHCH.sub.3, CNHCOOCH.sub.3, or C-NHCN. B is CH.sub.2, CH, C=O, N, NH or N-CH.sub.3 ; n is 0 or 1; and D is CH, CH.sub.2, C=O, 0, N, NH or N-CH.sub.3. These new compounds are suitable for treating schizophrenia, Parkinson's disease, anxiety, depression or as compounds for lowering blood pressure in animal or human hosts.
含有三环氮化合物,具有以下结构式的中枢神经系统活性:##STR1##和其药学上可接受的盐,其中R.sub.1,R.sub.2和R.sub.3独立地是氢,C.sub.1-6烷基,烯基或炔基,C.sub.3-10环烷基,或R.sub.1和R.sub.2连接形成可以包含额外杂原子的C.sub.3-7环胺;X是氢,C.sub.1-6烷基,卤素,羟基,烷氧基,氰基,羧酰胺,羧基或羧基烷氧基;A是SO.sub.2,N,CH,CH.sub.2,CHCH.sub.3,C=O,C=S,C-SCH.sub.3,C=NH,C-NH.sub.2,C-NHCH.sub.3,CNHCOOCH.sub.3或C-NHCN。B是CH.sub.2,CH,C=O,N,NH或N-CH.sub.3;n为0或1;D是CH,CH.sub.2,C=O,0,N,NH或N-CH.sub.3。这些新化合物适用于治疗精神分裂症、帕金森病、焦虑症、抑郁症或作为降低动物或人体内血压的化合物。